Choong Ang Vaccine Laboratory Co. Ltd (072020) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.022x

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.30 Billion ≈ $1.56 Million USD) by net assets (₩106.81 Billion ≈ $72.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 072020 net asset quality index to measure how much of total assets are equity-financed.

Choong Ang Vaccine Laboratory Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 072020 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SERESCO (ACC.P.DESD.)-16 F:XV7	N/A
POBIS TNC CO. Ltd KQ:016670	0.095x
MCE Holdings Bhd KLSE:7004	-0.006x
Empresas la Polar SA SN:ABC	0.122x
Savezone I C KO:067830	-0.003x
Multifiling Mitra Indonesia JK:MFMI	0.602x
Fiducial Office Solutions PA:SACI	-0.086x
Farmsco KO:036580	0.097x

Annual Cash Flow Conversion Efficiency for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see 072020 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩105.37 Billion ≈ $71.41 Million	₩7.87 Billion ≈ $5.33 Million	0.075x	-42.10%
2024-12-31	₩103.87 Billion ≈ $70.39 Million	₩13.40 Billion ≈ $9.08 Million	0.129x	+1.35%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	₩12.71 Billion ≈ $8.61 Million	0.127x	+71.24%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	₩7.09 Billion ≈ $4.80 Million	0.074x	-40.02%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	₩11.53 Billion ≈ $7.81 Million	0.124x	+30.51%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	₩8.32 Billion ≈ $5.64 Million	0.095x	-1.15%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	₩8.30 Billion ≈ $5.62 Million	0.096x	+43.06%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	₩5.71 Billion ≈ $3.87 Million	0.067x	-42.55%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	₩7.56 Billion ≈ $5.12 Million	0.117x	-8.46%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	₩7.71 Billion ≈ $5.23 Million	0.128x	-29.41%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	₩9.93 Billion ≈ $6.73 Million	0.181x	+41.03%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	₩6.67 Billion ≈ $4.52 Million	0.128x	--

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$57.71 Million

₩85.16 Billion KRW

Market Cap Rank

#21304 Global

#1198 in Korea

Share Price

₩9200.00

Change (1 day)

+1.10%

52-Week Range

₩8780.00 - ₩10140.00

All Time High

₩30815.73